首页> 外文期刊>Diabetes technology & therapeutics >ROSSO-in-praxi: a self-monitoring of blood glucose-structured 12-week lifestyle intervention significantly improves glucometabolic control of patients with type 2 diabetes mellitus.
【24h】

ROSSO-in-praxi: a self-monitoring of blood glucose-structured 12-week lifestyle intervention significantly improves glucometabolic control of patients with type 2 diabetes mellitus.

机译:ROSSO-in-praxi:对血糖结构化的12周生活方式干预的自我监测可显着改善2型糖尿病患者的糖代谢控制。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: As healthy diet and physical activity can improve glucometabolic control in patients with type 2 diabetes, lifestyle changes should be the basis for each therapy. The only tool to visualize immediate effects of food pattern and exercise on blood glucose levels is self-monitoring of blood glucose (SMBG). Therefore, the aim of the 12-week lifestyle intervention ROSSO-in-praxi was to evaluate the impact of an SMBG-structured motivation and education program on glucometabolic and health parameters in diabetes patients not treated with insulin. METHODS: Participants (n = 405) generated a seven-point blood glucose diurnal profile every 4 weeks, including actual weight, waist circumference, and steps/day. At baseline and the end of the study, glycated hemoglobin A1c (HbA1c), blood pressure, and cholesterol levels, lifestyle changes, and well-being (SF36 and Center for Epidemiologic Studies Depression Scale questionnaires) were assessed. RESULTS: Three hundred twenty-seven participants (81%) completed the program and significantly improved quality of diet and physical activity, accompanied by an increase of >2,300 steps/day. Participants significantly reduced weight, body mass index, waist circumference, blood glucose, blood pressure, low-density lipoprotein cholesterol, and HbA1c by 0.3% (all P < 0.001), accompanied by increased physical and mental health and reduced depression measurements. Weight loss was significantly associated with overall improvements of glucometabolic and health parameters and mean reduction of 0.05% HbA1c/kg. CONCLUSIONS: The evaluated SMBG-structured lifestyle intervention is applicable to motivate individuals with type 2 diabetes for lifestyle changes. Integration of this short-term, highly motivational, and low-cost intervention into basic therapy for patients without insulin therapy could strengthen patient empowerment in order to change lifestyle and to improve glucometabolic and general health.
机译:背景:由于健康的饮食和身体活动可以改善2型糖尿病患者的糖代谢控制,因此改变生活方式应成为每种疗法的基础。可视化食物模式和运动对血糖水平的即时影响的唯一工具是血糖自我监测(SMBG)。因此,为期12周的ROSSO-in-praxi生活方式干预的目的是评估SMBG结构的动机和教育计划对未经胰岛素治疗的糖尿病患者糖代谢和健康参数的影响。方法:参与者(n = 405)每4周产生7点血糖昼夜曲线,包括实际体重,腰围和步数/天。在基线和研究结束时,评估了糖化血红蛋白A1c(HbA1c),血压,胆固醇水平,生活方式的改变和幸福感(SF36和流行病学研究中心抑郁量表问卷)。结果:237名参与者(81%)完成了该计划,显着改善了饮食和体育锻炼的质量,并增加了每天超过2,300步。参与者的体重,体重指数,腰围,血糖,血压,低密度脂蛋白胆固醇和HbA1c显着降低了0.3%(所有P <0.001),同时身心健康提高,抑郁测量降低。体重减轻与糖代谢和健康参数的整体改善以及平均降低0.05%HbA1c / kg显着相关。结论:评估的SMBG结构的生活方式干预适用于激励2型糖尿病患者改变生活方式。对于没有胰岛素治疗的患者,将这种短期,高度积极,低成本的干预措施整合到基础治疗中可以增强患者的权能,从而改变生活方式,改善糖代谢和总体健康。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号